A Phase 3 Study of 2 Dose Regimens of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin...... Grant uri icon

Overview

total award amount

  • 159745.57

direct costs

  • 127796.46

sponsor award id

  • VX07-950-108

Background

Time

date/time interval

  • March 10, 2008 - March 24, 2011

Identity

DSR Number

  • 08082957
  • 08120257
  • 10102756

PeopleSoft Contract Number

  • 00068352

local award id

  • 00068352